FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mark Espeland

Research Profile

Procedures

Concepts & Ideas

Chemicals & Drugs

Physiology

Disorders

Anatomy

Carotid Arteries

Activities & Behaviors

Smoking

Co-author Network

Publications

TOP 3
Richard R Rubin; Monika Safford; Thomas A Wadden; Don Williamson; Rena R Wing; Mark A Espeland; Gina Evans-Hudnall; Linda Ewing; Lucy F Faulconbridge; Sarah A Gaussoin; William C Knowler; Mark Peyrot
Four-Year Analysis of Cardiovascular Disease Risk Factors, Depression Symptoms, and Antidepressant Medicine Use in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Diabetes.
Mark A Espeland; Karen L Falkner; Julie R Hunt; Marian Limacher; Cynthia McQuellon; Mary Pettinger; Sally A Shumaker; Marcia L Stefanick; Fridtjof Thomas; Kathryn E Weaver; Karen C Johnson
Demographic and health factors associated with enrollment in posttrial studies: The women's health initiative hormone therapy trials.
Mark A Espeland; Joseph S Goveas; Patricia E Hogan; Simin Liu; Kamal Masaki; Susan M Resnick; Jennifer G Robinson; Rebecca Rossom; Mustafa S Siddiqui; Kristine Yaffe; R Nick Bryan; Ramon Casanova; Laura H Coker
Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mark Espeland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Richard R Rubin; Monika Safford; Thomas A Wadden; Don Williamson; Rena R Wing; Mark A Espeland; Gina Evans-Hudnall; Linda Ewing; Lucy F Faulconbridge; Sarah A Gaussoin; William C Knowler; Mark Peyrot
Four-Year Analysis of Cardiovascular Disease Risk Factors, Depression Symptoms, and Antidepressant Medicine Use in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Diabetes.
Diabetes care 2013;36(5):1088-94.
2013: Mark A Espeland; Karen L Falkner; Julie R Hunt; Marian Limacher; Cynthia McQuellon; Mary Pettinger; Sally A Shumaker; Marcia L Stefanick; Fridtjof Thomas; Kathryn E Weaver; Karen C Johnson
Demographic and health factors associated with enrollment in posttrial studies: The women's health initiative hormone therapy trials.
Clinical trials (London, England) 2013;10(3):463-72.
2013: Mark A Espeland; Joseph S Goveas; Patricia E Hogan; Simin Liu; Kamal Masaki; Susan M Resnick; Jennifer G Robinson; Rebecca Rossom; Mustafa S Siddiqui; Kristine Yaffe; R Nick Bryan; Ramon Casanova; Laura H Coker
Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies.
Diabetes care 2013;36(1):90-7.
2012: Nancy Fugate Woods; Oleg Zaslavsky; Jeannette M Beasley; Robert L Brunner; Barbara B Cochrane; Mark A Espeland; Joseph S Goveas; Andrea Z LaCroix; Dorothy S Lane; Jingmin Liu; JoAnn E Manson; Charles P Mouton; Jennifer G Robinson; Rebecca A Seguin; Lesley F Tinker
Toward a positive aging phenotype for older women: observations from the women's health initiative.
The journals of gerontology. Series A, Biological sciences and medical sciences 2012;67(11):1191-6.
2012: Rebecca H Neiberg; David M Reboussin; Amy D Rickman; Rena R Wing; George A Bray; Mark A Espeland; Lucy F Faulconbridge; Karen C Johnson; Abbas E Kitabchi; Dalane W Kitzman
Patterns of weight change associated with long-term weight change and cardiovascular disease risk factors in the Look AHEAD Study.
Obesity (Silver Spring, Md.) 2012;20(10):2048-56.
2012: Stephen R Rapp; Susan M Resnick; Sally A Shumaker; Laura H Coker; Maggie Dailey; Mark A Espeland; Patricia E Hogan; Claudine Legault
Validation of a cognitive assessment battery administered over the telephone.
Journal of the American Geriatrics Society 2012;60(9):1616-23.
2012: Joseph S Goveas; Patricia E Hogan; Jane Morley Kotchen; JoAnn E Manson; W. Mysiw; Judith K Ockene; Jordan W Smoller; Aruna Tummala; Natalie L Denburg; Mark A Espeland; Nancy F Woods; Sylvia Wassertheil-Smoller
Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study.
International psychogeriatrics / IPA 2012;24(8):1252-64.
2012: Alain G Bertoni; Mark A Espeland; Dalane W Kitzman; Santica M Marcovina; Julia T Rushing; Lynne E Wagenknecht
Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.
Obesity (Silver Spring, Md.) 2012;20(7):1511-8.
2012: David L Mount; Susan Raatz; Sheikilya Thomas; Cralen Davis; Kathy Dotson; Mark A Espeland; Tiffany L Gary; Karen C Johnson; Betty Kennedy
Factors influencing enrollment of African Americans in the Look AHEAD trial.
Clinical trials (London, England) 2012;9(1):80-9.
2012: R Casanova; Mark A Espeland; B Wagner; Christopher T Whitlow; Joseph A Maldjian
Combining graph and machine learning methods to analyze differences in functional connectivity across sex.
The open neuroimaging journal 2012;6():1-9.
2011: Mark A Espeland; Joseph S Goveas; Patricia E Hogan; Michael E Miller; Michelle Naughton; Jeff Williamson; Susan M Resnick; Laura H Coker
Cognitive function and fine motor speed in older women with diabetes mellitus: results from the women's health initiative study of cognitive aging.
Journal of women's health (2002) 2011;20(10):1435-43.
2011: Ira Driscoll; Mark A Espeland; Sarah A Gaussoin; Iris A Granek; Judith K Ockene; Lawrence S Phillips; Susan M Resnick; Sylvia Wassertheil-Smoller; Kristine Yaffe; Jingzhong Ding
Weight change and cognitive function: findings from the Women's Health Initiative Study of Cognitive Aging.
Obesity (Silver Spring, Md.) 2011;19(8):1595-600.
2011: Joseph S Goveas; Mark A Espeland; Patricia Hogan; Vonetta Dotson; Sergey Tarima; Laura H Coker; Judith Ockene; Robert Brunner; Nancy F Woods; Sylvia Wassertheil-Smoller; Jane M Kotchen; Susan Resnick
Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: the Women's Health Initiative MRI Study.
Journal of affective disorders 2011;132(1-2):275-84.
2011: Ramon Casanova; Mark A Espeland; Joseph S Goveas; Christos Davatzikos; Sarah A Gaussoin; Joseph A Maldjian; Robert L Brunner; Lewis H Kuller; Karen C Johnson; W. Mysiw; Benjamin Wagner; Susan M Resnick
Application of machine learning methods to describe the effects of conjugated equine estrogens therapy on region-specific brain volumes.
Magnetic resonance imaging 2011;29(4):546-53.
2011: Mark A Espeland; Stephen R Rapp; Jeffrey A Katula; Lee Ann Andrews; Deborah Felton; Sarah A Gaussoin; Dale Dagenbach; Claudine Legault; Janine M Jennings; Kaycee M Sink
Telephone interview for cognitive status (TICS) screening for clinical trials of physical activity and cognitive training: the seniors health and activity research program pilot (SHARP-P) study.
International journal of geriatric psychiatry 2011;26(2):135-43.
2011: Ramon Casanova; Joseph A Maldjian; Sally A Shumaker; Benjamin Wagner; Christopher T Whitlow; Jeff Williamson; Mark A Espeland
High dimensional classification of structural MRI Alzheimer's disease data based on large scale regularization.
Frontiers in neuroinformatics 2011;5():22.
2011: Claudine Legault; Stephen R Rapp; W Jack Rejeski; Sally A Shumaker; Kaycee M Sink; Dale Dagenbach; Mark A Espeland; Sarah A Gaussoin; Janine M Jennings; Jeffrey A Katula
Designing clinical trials for assessing the effects of cognitive training and physical activity interventions on cognitive outcomes: the Seniors Health and Activity Research Program Pilot (SHARP-P) study, a randomized controlled trial.
BMC geriatrics 2011;11():27.
2011: Diana R Kerwin; Sarah A Gaussoin; Rowan T Chlebowski; Lewis H Kuller; Mara Vitolins; Laura H Coker; Jane Morley Kotchen; Barbara J Nicklas; Sylvia Wassertheil-Smoller; Raymond G Hoffmann; Mark A Espeland
Interaction between body mass index and central adiposity and risk of incident cognitive impairment and dementia: results from the Women's Health Initiative Memory Study.
Journal of the American Geriatrics Society 2011;59(1):107-12.
2010: Mark A Espeland; Robert L Brunner; Patricia E Hogan; Stephen R Rapp; Laura H Coker; Claudine Legault; Iris A Granek; Susan M Resnick
Long-term effects of conjugated equine estrogen therapies on domain-specific cognitive function: results from the Women's Health Initiative study of cognitive aging extension.
Journal of the American Geriatrics Society 2010;58(7):1263-71.
2010: Mark A Espeland; Sally A Shumaker; Marian C Limacher; Stephen R Rapp; Therese B Bevers; David H Barad; Laura H Coker; Sarah A Gaussoin; Marcia L Stefanick; Dorothy S Lane; Pauline M Maki; Susan M Resnick
Relative effects of tamoxifen, raloxifene, and conjugated equine estrogens on cognition.
Journal of women's health (2002) 2010;19(3):371-9.
2010: Hal H Atkinson; Stephen R Rapp; Jeff D Williamson; James Lovato; John R Absher; Margery Gass; Victor W Henderson; Karen C Johnson; John B Kostis; Kaycee M Sink; Charles P Mouton; Judith K Ockene; Marcia L Stefanick; Dorothy S Lane; Mark A Espeland
The relationship between cognitive function and physical performance in older women: results from the women's health initiative memory study.
The journals of gerontology. Series A, Biological sciences and medical sciences 2010;65(3):300-6.
2010: Laura H Coker; Mark A Espeland; Stephen R Rapp; Claudine Legault; Susan M Resnick; Patricia Hogan; Sarah Gaussoin; Maggie Dailey; Sally A Shumaker
Postmenopausal hormone therapy and cognitive outcomes: the Women's Health Initiative Memory Study (WHIMS).
The Journal of steroid biochemistry and molecular biology 2010;118(4-5):304-10.
2010: Jonathan Burdette; Paul J Laurienti; Mark A Espeland; Ashley Morgan; Qawi Telesford; Crystal D Vechlekar; Satoru Hayasaka; Janine M Jennings; Jeffrey A Katula; Robert A Kraft; W Jack Rejeski
Using network science to evaluate exercise-associated brain changes in older adults.
Frontiers in aging neuroscience 2010;2():23.
2010: Janet A Tooze; Sarah A Gaussoin; Susan M Resnick; Nancy J Fischbein; Jennifer G Robinson; R Nick Bryan; Yang An; Mark A Espeland
A uniform approach to modeling risk factor relationships for ischemic lesion prevalence and extent: the Women's Health Initiative Magnetic Resonance Imaging study.
Neuroepidemiology 2010;34(1):55-62.
2010: Jeffrey A Katula; Mara Z Vitolins; Erica L Rosenberger; Caroline Blackwell; Mark A Espeland; Michael S Lawlor; W Jack Rejeski; David C Goff
Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods.
Contemporary clinical trials 2010;31(1):71-81.
2009: Mark A Espeland; Hilary A Tindle; Cheryl A Bushnell; Sarah A Jaramillo; Lewis H Kuller; Karen L Margolis; W. Mysiw; Joseph A Maldjian; Elias Melhem; Susan M Resnick
Brain volumes, cognitive impairment, and conjugated equine estrogens.
The journals of gerontology. Series A, Biological sciences and medical sciences 2009;64(12):1243-50.
2009: Susan M Resnick; Mark A Espeland; Yang An; Pauline M Maki; Laura H Coker; Rebecca Jackson; Marcia L Stefanick; Robert Wallace; Stephen R Rapp
Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy.
The Journal of clinical endocrinology and metabolism 2009;94(11):4152-61.
2009: Mark A Espeland; George A Bray; Rebecca Neiberg; W Jack Rejeski; William C Knowler; Wei Lang; Lawrence J Cheskin; Don Williamson; C Beth Lewis; Rena Wing
Describing patterns of weight changes using principal components analysis: results from the Action for Health in Diabetes (Look AHEAD) research group.
Annals of epidemiology 2009;19(10):701-10.
2009: Jingzhong Ding; Fang-Chi Hsu; Tamara B Harris; Yongmei Liu; Stephen B Kritchevsky; Moyses Szklo; Pamela Ouyang; Mark A Espeland; Kurt Lohman; Michael H Criqui; Matthew Allison; David A Bluemke; John Carr
The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA).
The American journal of clinical nutrition 2009;90(3):499-504.
2009: Thomas H Alexander; Michael H Weisman; Jennifer M Derebery; Mark A Espeland; Bruce J Gantz; A Julianna Gulya; Paul E Hammerschlag; Maureen Hannley; Gordon B Hughes; Richard Moscicki; Ralph A Nelson; John K Niparko; Steven Rauch; Steven A Telian; Patrick E Brookhouser; Jeffrey P Harris
Safety of high-dose corticosteroids for the treatment of autoimmune inner ear disease.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2009;30(4):443-8.
2009: Jeff D Williamson; Mark A Espeland; Stephen B Kritchevsky; Anne B Newman; Abby C King; Marco Pahor; Jack M Guralnik; Leslie A Pruitt; Michael E Miller
Changes in cognitive function in a randomized trial of physical activity: results of the lifestyle interventions and independence for elders pilot study.
The journals of gerontology. Series A, Biological sciences and medical sciences 2009;64(6):688-94.
2009: W Jack Rejeski; Anthony P Marsh; Elizabeth Chmelo; Abbie J Prescott; Meredith Dobrosielski; Michael P Walkup; Mark A Espeland; Michael E Miller; Stephen B Kritchevsky
The Lifestyle Interventions and Independence for Elders Pilot (LIFE-P): 2-year follow-up.
The journals of gerontology. Series A, Biological sciences and medical sciences 2009;64(4):462-7.
2008: Jennifer A Cann; Thomas C Register; Michael R Adams; Richard W St Clair; Mark A Espeland; J Koudy Williams
Timing of estrogen replacement influences atherosclerosis progression and plaque leukocyte populations in ApoE-/- mice.
Atherosclerosis 2008;201(1):43-52.
2008: Mark A Espeland; Judith G Regensteiner; Sarah A Jaramillo; Edward Gregg; William C Knowler; Lynne E Wagenknecht; Judy Bahnson; Steven M Haffner; James Hill; William R Hiatt
Measurement characteristics of the ankle-brachial index: results from the Action for Health in Diabetes study.
Vascular medicine (London, England) 2008;13(3):225-33.
2007: Mark A Espeland; Thomas M Gill; Jack Guralnik; Michael E Miller; Roger Fielding; Anne B Newman; Marco Pahor
Designing clinical trials of interventions for mobility disability: results from the lifestyle interventions and independence for elders pilot (LIFE-P) trial.
The journals of gerontology. Series A, Biological sciences and medical sciences 2007;62(11):1237-43.
2007: Sarah A Jaramillo; Deborah Felton; Leeann Andrews; Lisa Desiderio; Rose K Hallarn; Sharon D Jackson; Laura H Coker; Jennifer G Robinson; Judith K Ockene; Mark A Espeland
Enrollment in a brain magnetic resonance study: results from the Women's Health Initiative Memory Study Magnetic Resonance Imaging Study (WHIMS-MRI).
Academic radiology 2007;14(5):603-12.
2007: Margaret Harper; Elizabeth Dugan; Mark A Espeland; Anibal Martinez-Borges; Cynthia Mcquellon
Why African-American women are at greater risk for pregnancy-related death.
Annals of epidemiology 2007;17(3):180-5.
2007: Mark S Chambers; Terence J Fleming; Béla B Toth; James C Lemon; Timothy E Craven; Otis J Bouwsma; Adam S Garden; Mark A Espeland; Harris J Keene; Jack W Martin; Tibor Sipos
Erratum to "Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study".
Oral oncology 2007;43(1):98-105.
2006: Mark A Espeland; Victor W. Henderson
Preventing cognitive decline in usual aging.
Archives of internal medicine 2006;166(22):2433-4.
2006: Susan M Resnick; Pauline M Maki; Stephen R Rapp; Mark A Espeland; Robert Brunner; Laura H Coker; Iris A Granek; Patricia Hogan; Judith K Ockene; Sally A Shumaker
Effects of combination estrogen plus progestin hormone treatment on cognition and affect.
The Journal of clinical endocrinology and metabolism 2006;91(5):1802-10.
2006: Mark A Espeland; K Dotson; Sarah A Jaramillo; S E Kahn; B Harrison; M Montez; J P Foreyt; B Montgomery; W C Knowler
Consent for genetics studies among clinical trial participants: findings from Action for Health in Diabetes (Look AHEAD).
Clinical trials (London, England) 2006;3(5):443-56.
2006: Mark A Espeland; Stephen R Rapp; Julia Robertson; Iris A Granek; Carol Murphy; Marilyn S Albert; Tamsen Bassford
Benchmarks for designing two-stage studies using modified mini-mental state examinations: experience from the Women's Health Initiative Memory Study.
Clinical trials (London, England) 2006;3(2):99-106.
2006: Mark A Espeland; Laura H Coker; Robert Wallace; Stephen R Rapp; Susan M Resnick; Marian C Limacher; Lynda H Powell; Catherine R Messina
Association between alcohol intake and domain-specific cognitive function in older women.
Neuroepidemiology 2006;27(1):1-12.
2005: John K Niparko; Nae-Yuh Wang; Steven Rauch; Gregory B Russell; Mark A Espeland; June J Pierce; Stephen Bowditch; Ann Masuda; A Julianna Gulya; Bruce J Gantz; Gordon B Hughes; Patrick E Brookhouser; Maureen Hannley; Steven A Telian; Jeffrey P Harris
Serial audiometry in a clinical trial of AIED treatment.
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2005;26(5):908-17.
2005: James G Terry; John Carr; Rong Tang; Gregory Evans; Ethel O Kouba; Rong Shi; Delilah R Cook; Jose L C Vieira; Mark A Espeland; Michele F Mercuri; John R Crouse
Coronary artery calcium outperforms carotid artery intima-media thickness as a noninvasive index of prevalent coronary artery stenosis.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(8):1723-8.
2005: Mark A Espeland; Lin Gu; Kamal H Masaki; Robert D Langer; Laura H Coker; Marcia L Stefanick; Judith K Ockene; Stephen R Rapp
Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study.
American journal of epidemiology 2005;161(3):228-38.
2004: Laura Loehr; Mark A Espeland; Kim Sutton-Tyrrell; Gregory L Burke; John R Crouse; David M Herrington
Racial differences in endothelial function in postmenopausal women.
American heart journal 2004;148(4):606-11.
2004: Mark A Espeland; Stephen R Rapp; Sally A Shumaker; Robert Brunner; JoAnn E Manson; Barbara B Sherwin; Judith Hsia; Karen L Margolis; Patricia E Hogan; Robert Wallace; Maggie Dailey; Ruth Freeman; Jennifer Hays
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
JAMA : the journal of the American Medical Association 2004;291(24):2959-68.
2004: Margaret A Harper; Mark A Espeland; Elizabeth Dugan; Robert Meyer; Kathy Lane; Sharon Wallace Williams
Racial disparity in pregnancy-related mortality following a live birth outcome.
Annals of epidemiology 2004;14(4):274-9.
2004: Susan M Resnick; Laura H Coker; Pauline M Maki; Stephen R Rapp; Mark A Espeland; Sally A Shumaker
The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline.
Clinical trials (London, England) 2004;1(5):440-50.
2003: Mark A Espeland; Gregory Evans; Lynne E Wagenknecht; Daniel H O'Leary; Daniel J Zaccaro; John R Crouse; George Howard; Steven M Haffner
Site-specific progression of carotid artery intimal-medial thickness.
Atherosclerosis 2003;171(1):137-43.
2003: Jeffrey P Harris; Michael H Weisman; Jennifer M Derebery; Mark A Espeland; Bruce J Gantz; A Julianna Gulya; Paul E Hammerschlag; Maureen Hannley; Gordon B Hughes; Richard Moscicki; Ralph A Nelson; John K Niparko; Steven Rauch; Steven A Telian; Patrick E Brookhouser
Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2003;290(14):1875-83.
2003: Margaret A Harper; Robert P Byington; Mark A Espeland; Michelle Naughton; Robert Meyer; Kathy Lane
Pregnancy-related death and health care services.
Obstetrics and gynecology 2003;102(2):273-8.
2003: Benoit C Pineau; Electra D Paskett; G John Chen; Mark A Espeland; Kim Phillips; James P Han; Claudia Mikulaninec; David J Vining
Virtual colonoscopy using oral contrast compared with colonoscopy for the detection of patients with colorectal polyps.
Gastroenterology 2003;125(2):304-10.
2003: Lynne E Wagenknecht; Daniel J Zaccaro; Mark A Espeland; Andrew J Karter; Daniel H O'Leary; Steven M Haffner
Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study.
Arteriosclerosis, thrombosis, and vascular biology 2003;23(6):1035-41.
2003: Stephen R Rapp; Mark A Espeland; Sally A Shumaker; Victor W. Henderson; Robert L Brunner; JoAnn E Manson; Margery Gass; Marcia L Stefanick; Dorothy S Lane; Jennifer Hays; Karen C Johnson; Laura H Coker; Maggie Dailey; Deborah Bowen
Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2003;289(20):2663-72.
2003: Stephen R Rapp; Mark A Espeland; Patricia Hogan; Beverly N Jones; Elizabeth Dugan
Baseline experience with Modified Mini Mental State Exam: The Women's Health Initiative Memory Study (WHIMS).
Aging & mental health 2003;7(3):217-23.
2003: James G Terry; Rong Tang; Mark A Espeland; Donna H Davis; Jose L C Vieira; Michele F Mercuri; John R Crouse
Carotid arterial structure in patients with documented coronary artery disease and disease-free control subjects.
Circulation 2003;107(8):1146-51.
2002: Mark A Espeland; Shiriki K Kumanyika; Carla Yunis; Beiyao Zheng; W Mark Brown; Sharon Jackson; Alan C Wilson; Judy Bahnson
Electrolyte intake and nonpharmacologic blood pressure control.
Annals of epidemiology 2002;12(8):587-95.
2002: John R Crouse; Rong Tang; Mark A Espeland; James G Terry; Timothy Morgan; Michele F Mercuri
Associations of extracranial carotid atherosclerosis progression with coronary status and risk factors in patients with and without coronary artery disease.
Circulation 2002;106(16):2061-6.
2002: John B Kostis; Alan C Wilson; W Craig Hooper; Kathryn W Harrison; Claire S Philipp; Lawrence J Appel; Mark A Espeland; Steven Folmar; Karen C Johnson
Association of angiotensin-converting enzyme DD genotype with blood pressure sensitivity to weight loss.
American heart journal 2002;144(4):625-9.
2002: Gail A Greendale; Mark A Espeland; Stacey Slone; Robert Marcus; Elizabeth Barrett-Connor
Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study.
Archives of internal medicine 2002;162(6):665-72.
2002: Shiriki K Kumanyika; Mark A Espeland; Judy Bahnson; Juliene B Bottom; Jeanne Charleston; Steven Folmar; Alan C Wilson; Paul K Whelton
Ethnic comparison of weight loss in the Trial of Nonpharmacologic Interventions in the Elderly.
Obesity research 2002;10(2):96-106.
2001: David M Herrington; Mark A Espeland; John R Crouse; J Robertson; Ward A Riley; Mary Ann McBurnie; Gregory L Burke
Estrogen replacement and brachial artery flow-mediated vasodilation in older women.
Arteriosclerosis, thrombosis, and vascular biology 2001;21(12):1955-61.
2001: David M Herrington; L Fan; M Drum; Ward A Riley; BE Pusser; John R Crouse; Gregory L Burke; Mary Ann McBurnie; Timothy M Morgan; Mark A Espeland
Brachial flow-mediated vasodilator responses in population-based research: methods, reproducibility and effects of age, gender and baseline diameter.
Journal of cardiovascular risk 2001;8(5):319-28.
2001: M E Miller; Timothy M Morgan; Mark A Espeland; Scott S Emerson
Group comparisons involving missing data in clinical trials: a comparison of estimates and power (size) for some simple approaches.
Statistics in medicine 2001;20(16):2383-97.
2001: Mark A Espeland; Shiriki K Kumanyika; Alan C Wilson; David M Reboussin; LH Easter; M Self; J Robertson; W M Brown; M McFarlane
Statistical issues in analyzing 24-hour dietary recall and 24-hour urine collection data for sodium and potassium intakes.
American journal of epidemiology 2001;153(10):996-1006.
2001: Lawrence J Appel; Mark A Espeland; LH Easter; Alan C Wilson; Steven Folmar; Clifton R Lacy
Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE).
Archives of internal medicine 2001;161(5):685-93.
2001: Mark A Espeland; Shiriki K Kumanyika; Alan C Wilson; Sara Wilcox; D Chao; Judy Bahnson; David M Reboussin; LH Easter; Beiyao Zheng
Lifestyle interventions influence relative errors in self-reported diet intake of sodium and potassium.
Annals of epidemiology 2001;11(2):85-93.
2001: Benoit C Pineau; Electra D Paskett; G John Chen; Valerie L Durkalski; Mark A Espeland; David J Vining
Validation of virtual colonoscopy in the detection of colorectal polyps and masses: rationale for proper study design.
International journal of gastrointestinal cancer 2001;30(3):133-40.
2000: Elizabeth Barrett-Connor; Mark A Espeland; Gail A Greendale; JF Trabal; S Johnson; Claudine Legault; Donna Kritz-Silverstein; P Einhorn
Postmenopausal hormone use following a 3-year randomized clinical trial.
Journal of women's health & gender-based medicine 2000;9(6):633-43.
2000: D Chao; Mark A Espeland; Deborah Farmer; Thomas C Register; Leon Lenchik; William B Applegate; Walter H Ettinger
Effect of voluntary weight loss on bone mineral density in older overweight women.
Journal of the American Geriatrics Society 2000;48(7):753-9.
1999: Maura K Whiteman; Yadong Cui; Jodi A Flaws; Mark A Espeland; Trudy L Bush
Low fibrinogen level: A predisposing factor for venous thromboembolic events with hormone replacement therapy.
American journal of hematology 1999;61(4):271-3.
1999: Robert P Byington; Gregory Evans; Mark A Espeland; William B Applegate; Donald B Hunninghake; Jeffrey L Probstfield; Curt D Furberg
Effects of lovastatin and warfarin on early carotid atherosclerosis: sex-specific analyses. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
Circulation 1999;100(3):e14-7.
1999: Mark A Espeland; Paul K Whelton; John B Kostis; Judy Bahnson; Walter H Ettinger; Jeffrey A Cutler; Lawrence J Appel; Shiriki K Kumanyika; Deborah Farmer; JT Elam; Alan C Wilson; William B Applegate
Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly.
Archives of family medicine 1999;8(3):228-36.
1999: Mark A Espeland; Rong Tang; James G Terry; Donna H Davis; Michele F Mercuri; John R Crouse
Associations of risk factors with segment-specific intimal-medial thickness of the extracranial carotid artery.
Stroke; a journal of cerebral circulation 1999;30(5):1047-55.
1999: Mark A Espeland; Timothy E Craven; M E Miller; R D'Agostino
1996 Remington lecture: modeling multivariate longitudinal data that are incomplete.
Annals of epidemiology 1999;9(3):196-205.
1998: Sally A Shumaker; Beth A Reboussin; Mark A Espeland; Stephen R Rapp; W L McBee; Maggie Dailey; D Bowen; T Terrell; Beverly N Jones
The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia.
Controlled clinical trials 1998;19(6):604-21.
1998: Mark A Espeland
Cardioprotective effects of postmenopausal hormone treatment.
The American journal of cardiology 1998;82(10A):37S-39S.
1998: Mark A Espeland; P E Hogan; SE Fineberg; George Howard; Helmut Schrott; MA Waclawiw; Trudy L Bush
Effect of postmenopausal hormone therapy on glucose and insulin concentrations. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.
Diabetes care 1998;21(10):1589-95.
1998: Beth A Reboussin; Gail A Greendale; Mark A Espeland
Effect of hormone replacement therapy on self-reported cognitive symptoms: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
Climacteric : the journal of the International Menopause Society 1998;1(3):172-9.
1998: Claudine Legault; Mark A Espeland; Carol Wasilauskas; Trudy L Bush; JF Trabal; HL Judd; Susan R Johnson; Gail A Greendale
Agreement in assessing endometrial pathology: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research 1998;7(4):435-42.
1998: Paul K Whelton; Lawrence J Appel; Mark A Espeland; William B Applegate; Walter H Ettinger; John B Kostis; Shiriki K Kumanyika; Clifton R Lacy; Karen C Johnson; Steven Folmar; Jeffrey A Cutler
Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.
JAMA : the journal of the American Medical Association 1998;279(11):839-46.
1998: Mark A Espeland; S M Marcovina; V Miller; P D Wood; Carol Wasilauskas; Roger Sherwin; Helmut Schrott; Trudy L Bush
Effect of postmenopausal hormone therapy on lipoprotein(a) concentration. PEPI Investigators. Postmenopausal Estrogen/Progestin Interventions.
Circulation 1998;97(10):979-86.
1997: R D Langer; J J Pierce; K A O'Hanlan; Susan R Johnson; Mark A Espeland; JF Trabal; Vanessa M Barnabei; M J Merino; R E Scully
Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial.
The New England journal of medicine 1997;337(25):1792-8.
1997: Gail A Greendale; MK James; Mark A Espeland; Elizabeth Barrett-Connor
Can we measure prior postmenopausal estrogen/progestin use? The Postmenopausal Estrogen/Progestin Interventions Trial. The PEPI Investigators.
American journal of epidemiology 1997;146(9):763-70.
1997: Elizabeth Barrett-Connor; S Slone; Gail A Greendale; Donna Kritz-Silverstein; Mark A Espeland; Susan R Johnson; MA Waclawiw; SE Fineberg
The Postmenopausal Estrogen/Progestin Interventions Study: primary outcomes in adherent women.
Maturitas 1997;27(3):261-74.
1997: Mark A Espeland; Marcia L Stefanick; Donna Kritz-Silverstein; SE Fineberg; MA Waclawiw; MK James; Gail A Greendale
Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators.
The Journal of clinical endocrinology and metabolism 1997;82(5):1549-56.
1997: Paul K Whelton; J Babnson; Lawrence J Appel; Jeanne Charleston; Nora M Cosgrove; Mark A Espeland; Steven Folmar; D Hoagland; S Krieger; Clifton R Lacy; L Lichtermann; F Oates-Williams; M Tayback; Alan C Wilson
Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE).
Journal of the American Geriatrics Society 1997;45(2):185-93.
1996: Mark A Espeland; S Kumanyika; John B Kostis; J Algire; William B Applegate; Walter H Ettinger; Paul K Whelton; Judy Bahnson
Antihypertensive medication use among recruits for the Trial of Nonpharmacologic Interventions in the Elderly (TONE).
Journal of the American Geriatrics Society 1996;44(10):1183-9.
1996: Elizabeth Barrett-Connor; Helmut Schrott; Gail A Greendale; Donna Kritz-Silverstein; Mark A Espeland; Michael P Stern; T Bush; J A Perlman
Factors associated with glucose and insulin levels in healthy postmenopausal women.
Diabetes care 1996;19(4):333-40.
1996: Michael E Miller; MK James; C D Langefeld; Mark A Espeland; J A Freedman; D K Martin; David M Smith
Some techniques for the analysis of work sampling data.
Statistics in medicine 1996;15(6):607-18.
1996: Mark A Espeland; Timothy E Craven; Ward A Riley; J Corson; A Romont; Curt D Furberg
Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Asymptomatic Carotid Artery Progression Study Research Group.
Stroke; a journal of cerebral circulation 1996;27(3):480-5.
1996: Therese A Dolecek; K H Bradham; Mark A Espeland; S E Margitic; Robert P Byington; H Hoen; L J Kappelle
Maximizing recruitment efforts in a drug lipid-lowering trial with dietary intervention to lower LDL cholesterol.
Controlled clinical trials 1996;17(1):33-45.
1995: Mark A Espeland; William B Applegate; Curt D Furberg; D Lefkowitz; L Rice; Donald B Hunninghake
Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study.
American journal of epidemiology 1995;142(10):1011-9.
1995: Robert P Byington; Curt D Furberg; John R Crouse; Mark A Espeland; M G Bond
Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II).
The American journal of cardiology 1995;76(9):54C-59C.
1995: Jeffrey L Probstfield; S E Margitic; Robert P Byington; Mark A Espeland; Curt D Furberg
Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study.
The American journal of cardiology 1995;76(9):47C-53C.
1995: Mark A Espeland; Trudy L Bush; I Mebane-Sims; Marcia L Stefanick; S Johnson; R Sherwin; M Waclawiw
Rationale, design, and conduct of the PEPI Trial. Postmenopausal Estrogen/Progestin Interventions.
Controlled clinical trials 1995;16(4 Suppl):3S-19S.
1995: Trudy L Bush; Mark A Espeland; I Mebane-Sims
The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. Introduction.
Controlled clinical trials 1995;16(4 Suppl):1S-2S.
1995: John R Crouse; Robert P Byington; M G Bond; Mark A Espeland; Timothy E Craven; J W Sprinkle; M E McGovern; Curt D Furberg
Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)
The American journal of cardiology 1995;75(7):455-9.
1994: Curt D Furberg; H P Adams; William B Applegate; Robert P Byington; Mark A Espeland; Tyler D Hartwell; Donald B Hunninghake; D S Lefkowitz; Jeffrey L Probstfield; Ward A Riley
Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.
Circulation 1994;90(4):1679-87.
1994: Mark A Espeland; H Hoen; Robert P Byington; George Howard; Ward A Riley; Curt D Furberg
Spatial distribution of carotid intimal-medial thickness as measured by B-mode ultrasonography.
Stroke; a journal of cerebral circulation 1994;25(9):1812-9.
1994: Curt D Furberg; Robert P Byington; John R Crouse; Mark A Espeland
Pravastatin, lipids, and major coronary events.
The American journal of cardiology 1994;73(15):1133-4.
1993: Jeffrey L Probstfield; Robert P Byington; DA Egan; Mark A Espeland; S E Margitic; Ward A Riley; Curt D Furberg
Methodological issues facing studies of atherosclerotic change.
Circulation 1993;87(3 Suppl):II74-81.
1992: John R Crouse; Robert P Byington; M G Bond; Mark A Espeland; J W Sprinkle; M McGovern; Curt D Furberg
Pravastatin, lipids, and atherosclerosis in the carotid arteries: design features of a clinical trial with carotid atherosclerosis outcome.
Controlled clinical trials 1992;13(6):495-506.
1992: Mark A Espeland; Robert P Byington; D Hire; V G Davis; Tyler D Hartwell; Jeffrey L Probstfield
Analysis strategies for serial multivariate ultrasonographic data that are incomplete.
Statistics in medicine 1992;11(8):1041-56.
1992: U E Zappa; Alan Polson; Mark A Espeland
Effect of metronidazole on experimental periodontitis: cell population characteristics.
Schweizer Monatsschrift für Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia / SSO 1992;102(2):178-83.
1991: Mark A Espeland; U E Zappa; P E Hogan; C Simona; H Graf
Cross-sectional and longitudinal reliability for clinical measurement of attachment loss.
Journal of clinical periodontology 1991;18(2):126-33.
1991: U E Zappa; Alan Polson; Mark A Espeland
Correlations between periodontal tissue breakdown and cell populations.
Schweizer Monatsschrift für Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia / SSO 1991;101(10):1279-85.
1990: Timothy E Craven; J E Ryu; Mark A Espeland; F R Kahl; W M McKinney; James F Toole; M R McMahan; C J Thompson; Gerardo Heiss; John R Crouse
Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.
Circulation 1990;82(4):1230-42.
1989: J E Ryu; K Murros; Mark A Espeland; J Rubens; W M McKinney; James F Toole; John R Crouse
Extracranial carotid atherosclerosis in black and white patients with transient ischemic attacks.
Stroke; a journal of cerebral circulation 1989;20(9):1133-7.
1988: J Rubens; Mark A Espeland; J Ryu; G Harpold; W M McKinney; F R Kahl; James F Toole; John R Crouse
Individual variation in susceptibility to extracranial carotid atherosclerosis.
Arteriosclerosis (Dallas, Tex.) 1988;8(4):389-97.
1986: Alan Polson; U E Zappa; Mark A Espeland; A D Eisenberg
Effect of metronidazole on development of subgingival plaque and experimental periodontitis.
Journal of periodontology 1986;57(4):218-24.
1986: U E Zappa; Alan Polson; A D Eisenberg; Mark A Espeland
Microbial populations and active tissue destruction in experimental periodontitis.
Journal of clinical periodontology 1986;13(2):117-25.